Kintor Pharmaceutical completes patient enrollment in KX-826 phase 2 trial

Kintor Pharmaceutical said that it has wrapped up patient enrollment for the phase 2 clinical trial of KX-826 (pyrilutamide) in China for the treatment of ... Read More